RE: Fast Track Designation Granted for Brepocitinib25 Sep 2024 09:32
Hi Krusty. I should just mention that I'm in neither camp. I have been here for around 6-7 years and certainly no expert. There are benefits to both of the scenarios you mention in your comment. That said, I would probably prefer if the results were stellar to move on to PH2 should the investment be plentiful and nailed on.